Provectus redeems 11.4M Series D shares for 1.14M Series D-1 shares; authorized share counts amended

PROVECTUS BIOPHARMACEUTICALS, INC.

VP and President Dominic Rodrigues forfeits 11,416,262 Series D Preferred shares for 1,141,626 Series D-1 shares.
Series D authorized shares reduced from 12,374,000 to 957,100; Series D-1 increased from 11,241,000 to 23,042,900.
Company states new Series D-1 shares are economically equivalent to the forfeited Series D shares.
Amendments to certificates of designation filed with Delaware Secretary of State on June 24, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.